Aoyama, Ryuhei
Tsunoda, Shigeru https://orcid.org/0000-0003-1468-7352
Okamura, Ryosuke
Yamashita, Yoshito
Hata, Hiroaki
Kinjo, Yosuke
Miki, Akira
Kanaya, Seiichiro
Yamamoto, Michihiro
Matsuo, Koichi
Manaka, Dai
Tanaka, Eiji
Kawada, Hironori
Kondo, Masato
Itami, Atsushi
Kan, Takatsugu
Kadokawa, Yoshio
Ito, Tetsuo
Hirai, Kenjiro
Hosogi, Hisahiro
Nishigori, Tatsuto
Hisamori, Shigeo
Hoshino, Nobuaki
Hida, Koya
Goto, Yoshihito
Nakayama, Takeo
Obama, Kazutaka
Article History
First Online: 3 March 2023
Disclosure
: Shigeru Tsunoda received lecture fees from Intuitive Surgical G.K., Covidien Japan Inc., Ethicon Inc., and Olympus Corporation. Yoshito Yamashita received lecture fees from Johnson and Johnson K.K. and Intuitive Surgical G.K. Tatsuto Nishigori received lecture fees from Olympus Corporation. Koya Hida received consulting fees from Nipro and lecture fees from Johnson and Johnson K.K. and Medtronic. Kazutaka Obama received lecture fees from Medtronic, Ethicon Inc., Olympus Corporation, Intuitive Surgical G.K., and Medicaroid. All fees were received outside of the submitted work. Takeo Nakayama reports personal fees from Pfizer Japan Inc., Ohtsuka Pharamaceutical co., Chugai Pharamaceutical co., Dentsu co., Takeda Pharamaceutical co., Janssen Pharmaceutical K.K., Boehringer Ingelheim International GmbH, Eli Lilly Japan K.K., Alexion, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Allergan Japan K.K., Maruho Co., Ltd., Novo Nordisk Pharma Ltd, GlaxoSmithKline K.K., MSD K.K.; and research grants from I&H Co., Ltd., Cocokarafine Group Co., Ltd., Konica Minolta, Inc. All of them were received outside the submitted work. The remaining authors have no conflicts of interest to declare, associated with this manuscript.